Mark Toland

Mark Toland is CEO of surgical robotics company MMI and managing director of BioStar Captial, an investment firm focused on medical technology. He previously served as president and CEO of Corindus, a vascular robotics company that Siemens Healthineers acquired for $1.1 billion in 2019, the fifth-largest medical technology acquisition that year.

Posts by Mark Toland

MedCity Influencers, Devices & Diagnostics

Medical Innovation Must Shift Focus From Common Problems to Unsolvable Ones

The innovator’s mindset is shifting from solving the problems right in front of us to solving problems once considered impossible to fix. The lines between curable and incurable diseases are blurring in surgery because medical devices are scaling up precision and scaling down the size of anatomy that surgeons can operate on.

Physicians

OmniLife Health’s Clinical Workflow Solution Focuses on Complex Care

OmniLife Health's initial focus with its complex care coordination platform is organ transplant care.

Health Tech

HealthBook+ CEO Shares Vision for How People Can Own Their Health by Leveraging Data and AI

HealthBook+ provides a way for individuals to aggregate and use their personal health information safely and securely to power AI engines that direct people to their next best health action. Importantly, it also gives employers predictive insights to help them provide the most relevant benefits for their employees.